[1]
M. Pasek, P. Arenberger, V. Tretera, M. Palkovsky, J. Vránová, and M. Arenbergerova, “Comparison of the Efficacy and Safety between Adjuvant and Palliative Anti-PD-1 Treatment of Stage 4 Oligometastatic Melanoma”, Dermatol Pract Concept, vol. 16, no. 1, p. 6483, Jan. 2026, doi: 10.5826/dpc.1601a6483.